cbdMD, Inc. Common Stock (YCBD) Stock Price

YCBDStock

$0.36−66.10%52W

Market Cap$3.99M

P/E—

PEG Ratio—

Div yield—

Beta2.34

YCBD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-61.00%

Price vs S&P 500 (4W)-17.77%

VGM Score52.21

Book Value / Share (Quarterly)$0.74

P/TBV (Annual)2.11x

Revenue Growth (3Y)-18.46%

Cash Flow / Share (Quarterly)$-0.22

Price vs S&P 500 (YTD)-85.56%

Gross Margin (TTM)57.68%

Net Profit Margin (TTM)-13.80%

EPS (TTM)$-0.29

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-0.29

Revenue Growth (5Y)-14.45%

EPS (Annual)$-0.51

Dividend / Share (Annual)$0.00

ROI (Annual)-28.24%

Gross Margin (Annual)62.37%

Net Profit Margin (5Y Avg)-75.03%

Cash / Share (Quarterly)$0.19

Revenue Growth QoQ (YoY)20.56%

ROA (Last FY)-19.59%

Revenue Growth TTM (YoY)10.01%

EBITD / Share (TTM)$-0.19

ROE (5Y Avg)-143.31%

Operating Margin (TTM)-13.87%

Cash Flow / Share (Annual)$-0.18

P/B Ratio0.56x

P/B Ratio (Quarterly)0.86x

Net Income / Employee (Annual)$-48,600

EV / Revenue (TTM)0.12x

Net Interest Coverage (TTM)-7.06x

ROA (TTM)-24.27%

EV / EBITDA (TTM)0.21x

EPS Incl Extra (Annual)$-0.51

Current Ratio (Annual)2.05x

Quick Ratio (Quarterly)1.26x

3-Month Avg Trading Volume0.35M

52-Week Price Return-66.10%

Revenue / Employee (TTM)$498,400

Tangible BV / Share (Quarterly)$0.56

P/S Ratio (Annual)0.24x

Asset Turnover (Annual)1.84x

52-Week High$2.56

Operating Margin (5Y Avg)-74.98%

EPS Excl Extra (Annual)$-0.51

CapEx CAGR (5Y)-32.56%

Tangible BV CAGR (5Y)-20.44%

26-Week Price Return-51.10%

Quick Ratio (Annual)1.03x

13-Week Price Return-37.53%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.50x

Enterprise Value$2.50M

Revenue / Share Growth (5Y)-35.24%

Asset Turnover (TTM)1.76x

Book Value / Share Growth (5Y)-58.51%

Revenue / Employee (Annual)$456,900

Inventory Turnover (Annual)2.83x

Pretax Margin (Annual)-10.63%

Cash / Share (Annual)$0.25

3-Month Return Std Dev73.08%

Gross Margin (5Y Avg)63.30%

Net Income / Employee (TTM)$-68,800

ROE (Last FY)-28.24%

Net Interest Coverage (Annual)-8.49x

EPS Basic Excl Extra (Annual)$-0.51

Receivables Turnover (TTM)15.39x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.29

Receivables Turnover (Annual)18.96x

ROI (TTM)-34.24%

P/S Ratio (TTM)0.22x

Pretax Margin (5Y Avg)-75.43%

Revenue / Share (Annual)$4.77

Tangible BV / Share (Annual)$0.57

Price vs S&P 500 (52W)-81.63%

Year-to-Date Return-73.63%

5-Day Price Return-0.06%

EPS Normalized (Annual)$-0.51

ROA (5Y Avg)-77.34%

Net Profit Margin (Annual)-10.63%

Month-to-Date Return-21.41%

Cash Flow / Share (TTM)$-15.00

EBITD / Share (Annual)$-0.26

Operating Margin (Annual)-11.27%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-129.07%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.29

P/TBV (Quarterly)1.13x

P/B Ratio (Annual)1.49x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.92x

Pretax Margin (TTM)-13.80%

Book Value / Share (Annual)$0.81

Price vs S&P 500 (13W)-40.22%

Dividend Yield (TTM)0.00%

Beta2.34x

Revenue / Share (TTM)$1.97

ROE (TTM)-34.25%

52-Week Low$0.33

vGradeB

gGradeC

mGradeD

vgmGradeC

YCBD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.03	-$0.11	-266.67%(-$0.08)
Q1 2026	May 14, 2026	-$0.05	-$0.08	-60.00%(-$0.03)
Q4 2025	Feb 17, 2026	-$0.06	-$0.04	+33.33%(+$0.02)
Q2 2025	Aug 14, 2025	-$0.16	-$0.21	-31.25%(-$0.05)

YCBD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

2.17

Industry Peers — Cosmetics & Toiletries(22)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
YCBDcbdMD, Inc. Common Stock	B	C	D	0.2x	10.0%	57.7%	—	$0.36
CLColgate-Palmolive Company	C	C	B	3.6x	5.2%	60.4%	-3.5%	$94.11
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	3.0x	1.2%	65.5%	8.3%	$10.13
ELThe Estee Lauder Companies Inc. Class A	D	D	A	2.5x	5.1%	75.5%	-42.3%	$104.54
KVUEKenvue Inc.	C	C	A	2.4x	1.8%	58.6%	—	$18.91
ELFe.l.f. Beauty, Inc.	D	B	A	3.8x	31.2%	74.4%	30.1%	$113.54
IPARInterparfums, Inc. Common Stock	C	B	B	2.5x	2.9%	55.8%	34.2%	$115.69
COTYCOTY INC	B	C	B	0.5x	-1.5%	62.9%	—	$3.20
EPCEdgewell Personal Care Company	B	D	B	0.6x	-7.0%	41.1%	-15.5%	$27.91
ODDODDITY Tech Ltd. Class A Ordinary Shares	C	C	B	1.5x	-9.7%	70.0%	50.4%	$22.43
YSGYatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares	A	C	C	0.4x	-1.6%	77.4%	—	$2.58
PTNMPitanium Limited Class A Ordinary shares	—	—	B	—	—	—	—	$10.39
WALDWaldencast plc Class A Ordinary Share	B	F	C	0.4x	-26.6%	66.1%	—	$0.88
SLSNSolesence, Inc. Common Stock	D	D	C	1.1x	-14.1%	26.9%	-0.8%	$0.90
AXILAXIL Brands, Inc.	B	B	B	1.2x	10.3%	72.4%	—	$5.46
UGUnited-Guardian, Inc.	B	D	B	2.8x	3.2%	46.9%	-8.6%	$6.84
CABRCaring Brands, Inc. Common Stock	—	—	C	—	—	—	—	$1.22
BNKKBonk, Inc. Common Stock	A	A	D	1.0x	2362.4%	55.4%	—	$1.21
BIOTInstinct Bio Technical Company Holdings Inc. Ordinary Shares	—	C	B	—	—	—	—	$0.23
BIOTWInstinct Bio Technical Company Holdings Inc. Warrants	—	—	A	—	—	—	—	$0.01
EMPGEmpro Group Inc. Ordinary shares	—	—	A	—	—	—	—	$0.00
OLPXOlaplex Holdings, Inc. Common Stock	C	D	B	3.3x	1.1%	71.2%	-20.8%	$0.00
WALDWWaldencast plc Warrant	—	—	F	—	—	—	—	$0.00

About cbdMD, Inc. Common Stock

cbdMD Inc is a United States-based consumer wellness company that manufactures and distributes CBD and functional mushroom products through three distinct brands: cbdMD, Paw CBD (pet-focused), and ATRx Labs. Its product portfolio includes tinctures, gummies, topicals, capsules, oils, and pet formulations distributed via e-commerce, wholesalers, and retail partnerships. This diversified brand and channel strategy positions the company across multiple consumer wellness segments.